Idana | Updates

By Lucas Spohn

Idana equips doctors for the new GDPR and increases funding goal


Dear Companists,

Digitalization is the greatest disruption of most areas of both public and private life. It is associated not only with new chances and opportunities to simplify daily work, but also with several challenges. Many users voice their concerns – a central question naturally refers to data protection: “Is my data secure?”   

Politicians have responded: The new European General Data Protection Regulation (GDPR), which regulates the processing, storage and transmission of "personal data", came into force in May 2016. The two-year transition period ends on 25 May 2018 after which the new provisions are effective immediately.

In this update, we will shed light on what this means for doctors who work with medical data, which is particularly sensitive personal data, in their day-to-day work, and how Idana supports them in implementing the guidelines of the new GDPR. We will also highlight the increase in the funding goal to €500,000.


A challenge for physicians: The new GDPR

For physicians, the new GDPR calls on physicians in hospitals and practices to develop an awareness of data protection - and threatens harsher sanctions against violations.


The new GDPR


Four areas are affected.

The new GDPR

1. requires physicians to organize internal data protection.
Ideally, physicians should introduce their own data protection management in their practices to demonstrate that the new data protection guidelines have been correctly implemented. This includes, among other things, the documentation of all data processing processes that take place in practice. Larger medical practices may also be required to appoint a data protection manager.

2. redefines the relationship with patients.
From now on, patients are to be better informed about which data are collected and processed. Special data processing procedures require the patient's consent. Patients have an extended right to information and can also request that their own data be deleted.

3. redefines the relationship with external service providers and third parties.
In the case of contracts with external service providers, the physician is now required to check whether the data protection regulations are fulfilled. This applies particularly to order processing.

4. expands the powers of the supervisory authorities.
So-called "trade secret bearers," such as doctors, continue to have only a limited obligation to provide information to the supervisory authorities - thus ensuring the protection of patient confidentiality. However, under the new GDPR, doctors are obliged to report data breaches and breakdowns, such as hacker attacks or by employees, in a timely manner.


Idana facilitates the transition

Idana supports physicians to master the challenge of the GDPR in their practices.

Due to our medical background, we know how important the protection of sensitive medical data is, wherefore we have developed an innovative data protection concept: Strong encryption via end-to-end encryption and the quasi-anonymization of patient data ensure that Idana is GDPR-compliant.

We also integrated a new patient questionnaire into our anamnesis database to inform patients about the data processing processes in the respective practice just in time for the new GDPR to take effect. This also makes it possible to obtain the patient's declaration of consent for data processing required by the GDPR and to store it securely.


Last but not least: Funding goal increased to €500,000

As a rather young company, Tomes GmbH faces a whole series of challenges: After completing the development of our next major software update in July, we will focus on sales and content development, both of which are resource-intensive, from the third quarter onwards. For this reason, we have decided to extend to increase the funding goal to €500,000. Continue to support us and work with us to make tomorrow's healthcare a reality.


Best greetings from Freiburg,
Lucas Spohn


Only registered Companists can comment. Please log in to leave a comment.


Investments in startups and growth companies offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, investments in startups or growth companies are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by diversifying the amount they invest in startups and growth companies and not investing the entire amount in one startup or growth company. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the investors on Companisto are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the investors (Companists) – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, investments in startups and growth companies are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

€ 500,000




22.58 %

Share Offered

Please note
The acquisition of this asset involves considerable risks and can lead to the complete loss of the assets used. The expected yield is not guaranteed and may turn out to be lower.
Contact Us
If you have any questions about investing on Companisto, please contact our service team:

Toll-free phone number for investors calling from Germany:
0800 - 100 267 0

Companisto investors hotline:
+49(0)30 - 346 491 493

We are available Monday through Friday between 9 a.m. – 7 p.m.

For companies
Apply for financing Investment Model FAQ for Companies
Investor Support
Please register in order to see the complete profile of Idana.
Already registered?    Log in